Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge

Clinical and Vaccine Immunology

Volumn 20, Issue 6, 2013, Pages 795-802

  Hu, Mingming ^a   Zhang, Yanhe ^a   Xie, Fang ^a   Li, Gang ^a   Li, Jianjun ^a   Si, Wei ^a   Liu, Siguo ^a   Hu, Shouping ^a   Zhang, Zhuo ^a   Shen, Nan ^a   Wang, Chunlai ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIN; GAMMA INTERFERON; HAEMOPHILUS PARASUIS GHOST VACCINE; HAEMOPHILUS VACCINE; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS PARASUIS; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; NONHUMAN; PIGLET; PRIORITY JOURNAL; PROTECTION; TH1 CELL; TH2 CELL; VACCINATION;

ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS PARASUIS; INTERFERON-GAMMA; INTERLEUKIN-4; SWINE; SWINE DISEASES; VACCINES, INACTIVATED;

EID: 84878319552     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00676-12     Document Type: Article

References (22)

1. Oliveira S, Pijoan C. 2004. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Vet. Microbiol. 99:1-12. (Pubitemid 38264508)
2. de la Fuente AJ, Gutierrez-Martin CB, Rodriguez-Barbosa JI, Martinez-Martinez S, Frandoloso R, Tejerina F, Rodriguez-Ferri EF. 2009. Blood cellular immune response in pigs immunized and challenged with Haemophilus parasuis. Res. Vet. Sci. 86:230 -234.
3. Zhou M, Guo Y, Zhao J, Hu Q, Hu Y, Zhang A, Chen H, Jin M. 2009. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5. Vaccine 27:5271-5277.
4. Rapp-Gabrielson VG, Kocur GJ, Clark JT, Muir SK. 1997. Haemophilus parasuis: immunity in swine after vaccination. Vet. Med. 92:83-90. (Pubitemid 127445191)
5. Martin de la Fuente AJ, Gutierrez Martin CB, Perez Martinez C, Garcia Iglesias MJ, Tejerina F, Rodriguez Ferri EF. 2009. Effect of different vaccine formulations on the development of Glasser's disease induced in pigs by experimental Haemophilus parasuis infection. J. Comp. Pathol. 140:169 -176.
6. Yuan F, Fu S, Hu J, Li J, Chang H, Hu L, Chen H, Tian Y, Bei W. 2012. Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model. Res. Vet. Sci. 93:51-56.
7. Huter V, Hensel A, Brand E, Lubitz W. 2000. Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine. J. Biotechnol. 83: 161-172.
8. Hensel A, Huter V, Katinger A, Raza P, Strnistschie C, Roesler U, Brand E, Lubitz W. 2000. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 18:2945-2955. (Pubitemid 30303796)
9. Peng W, Si W, Yin L, Liu H, Yu S, Liu S, Wang C, Chang Y, Zhang Z, Hu S, Du Y. 2011. Salmonella enteritidis ghost vaccine induces effective protection against lethal challenge in specific-pathogen-free chicks. Immunobiology 216:558 -565.
10. Witte A, Wanner G, Blasi U, Halfmann G, Szostak M, Lubitz W. 1990. Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E. J. Bacteriol. 172:4109-4114. (Pubitemid 20213400)
11. Witte A, Wanner G, Sulzner M, Lubitz W. 1992. Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch. Microbiol. 157:381-388.
12. Szostak MP, Hensel A, Eko FO, Klein R, Auer T, Mader H, Haslberger A, Bunka S, Wanner G, Lubitz W. 1996. Bacterial ghosts: non-living candidate vaccines. J. Biotechnol. 44:161-170. (Pubitemid 26059097)
13. Lubitz W, Witte A, Eko FO, Kamal M, Jechlinger W, Brand E, Marchart J, Haidinger W, Huter V, Felnerova D, Stralis-Alves N, Lechleitner S, Melzer H, Szostak MP, Resch S, Mader H, Kuen B, Mayr B, Mayrhofer P, Geretschlager R, Haslberger A, Hensel A. 1999. Extended recombinant bacterial ghost system. J. Biotechnol. 73:261-273. (Pubitemid 29376457)
14. Jalava K, Eko FO, Riedmann E, Lubitz W. 2003. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev. Vaccines 2:45-51. (Pubitemid 36559938)
15. Riedmann EM, Kyd JM, Cripps AW, Lubitz W. 2007. Bacterial ghosts as adjuvant particles. Expert Rev. Vaccines 6:241-253. (Pubitemid 46607459)
16. Lubitz P, Mayr UB, Lubitz W. 2009. Applications of bacterial ghosts in biomedicine. Adv. Exp. Med. Biol. 655:159 -170.
17. Ebensen T, Paukner S, Link C, Kudela P, de Domenico C, Lubitz W, Guzman CA. 2004. Bacterial ghosts are an efficient delivery system for DNA vaccines. J. Immunol. 172:6858-6865. (Pubitemid 38669124)
18. Mayr UB, Walcher P, Azimpour C, Riedmann E, Haller C, Lubitz W. 2005. Bacterial ghosts as antigen delivery vehicles. Adv. Drug Deliv. Rev. 57:1381-1391. (Pubitemid 40791117)
19. Walcher P, Mayr UB, Azimpour-Tabrizi C, Eko FO, Jechlinger W, Mayrhofer P, Alefantis T, Mujer CV, DelVecchio VG, Lubitz W. 2004. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev. Vaccines 3:681-691. (Pubitemid 39576756)
20. Oswald W, Tonpitak W, Ohrt G, Gerlach G. 1999. A single-step transconjugation system for the introduction of unmarked deletions into Actinobacillus pleuropneumoniae serotype 7 using a sucrose sensitivity marker. FEMS Microbiol. Lett. 179:153-160. (Pubitemid 29428218)
21. Appleyard GD, Furesz SE, Wilkie BN. 2002. Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae. Vet. Immunol. Immunopathol. 86:221-228. (Pubitemid 34465752)
22. Haslberger AG, Kohl G, Felnerova D, Mayr UB, Fürst-Ladani S, Lubitz W. 2000. Activation, stimulation and uptake of bacterial ghosts in antigen presenting cells. J. Biotechnol. 83:57-66.